The Impact of Post-Genomics Approaches in Neurodegenerative Demyelinating Diseases: The Case of Guillain-Barré Syndrome

E-ISSN： 1875-533x|25|29|3482-3490

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.25, Iss.29, 2018-09, pp. : 3482-3490

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel therapeutic approaches to Guillain-Barré syndrome

By Pritchard J.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 10, 2000-10 ,pp. : 2307-2318

Informa Healthcare

Access to resources Recommend Favorite

Major Surgery with Guillain–Barré Syndrome: a Case Report

By Koc M Ozalp N Zulfikaroglu B

The Journal of International Medical Research, Vol. 30, Iss. 6, 2002-11 ,pp. : 601-604

Field House Publishing

Access to resources Recommend Favorite

Efalizumab: Guillain-Barré syndrome: case report

Reactions Weekly, Vol. 1, Iss. 1321, 2010-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Vaccines and Guillain-Barré Syndrome

By Haber Penina

Drug Safety, Vol. 32, Iss. 4, 2009-01 ,pp. : 309-323

Adis International

Access to resources Recommend Favorite

Guillain-Barré syndrome

By Pritchard Jane

Clinical Medicine, Vol. 10, Iss. 4, 2010-08 ,pp. : 399-401

Royal College Of Physicians

Access to resources Recommend Favorite